Search
for
Sort by
Research 30 of 1000+
- P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
- 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- 41261 Identification of Demographic and Clinical Features Associated with Multi-Biologic Failure in the CorEvitas Psoriasis Registry
- 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Immune therapies for alopecia areata: evidence and new perspectives
- Alopecia Areata Associated with Dupilumab: National Database Study
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- LB922 CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- PSS36 ECONOMIC ANALYSIS OF CATARACT SURGERY IN EUROPE:AN ANALYSIS OF HOSPITAL DATABASES AVAILABLE IN 11 COUNTRIES
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Tissue engineering of skin and regenerative medicine for wound care
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Recent advances and challenges in 3D bioprinting for skin tissue regeneration
- Harnessing Regenerative Science in Aesthetic Surgery: The Biologically Driven Future
- Ottawa, Ontario, Canada, February 13–16, 2013
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- PSS35 COST COMPARISON OF PATIENTS WITH CHRONIC HAND ECZEMA COVERED BY STATUTORY VS. OCCUPATIONAL HEALTH INSURANCES IN GERMANY